World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
10059
World Ranking
4412
National Ranking
2003

Ann B. Hill publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ann B. Hill sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 112 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ann B. Hill D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ann B. Hill sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ann B. Hill is affiliated with Oregon Health & Science University in the United States. Their research work spans multiple areas within medicine and immunology, with a focus on immune cell function, viral infections, and cancer immunotherapy.

The main fields of study for this scientist include:

  • Medicine
  • Immunology and Microbiology

The key subfields they specialize in are:

  • Immunology
  • Oncology
  • Epidemiology
  • Organic Chemistry
  • Radiology, Nuclear Medicine and Imaging

Their research topics cover:

  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses

Ann B. Hill has contributed to the scientific literature with several publications, including the following recent papers:

  • PD-1-specific "Blocking" antibodies that deplete PD-1 + T cells present an inconvenient variable in preclinical immunotherapy experiments, 2021, European Journal of Immunology
  • Latent CMV infection of Lymphatic endothelial cells is sufficient to drive CD8 T cell memory inflation, 2023, PLoS Pathogens
  • Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature, 2021, The Journal of Immunology
  • Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo, 2020, mAbs
  • Phosphinoisocyanide/Alkyne Cycloaddition: Generation of Azaphospholylidene (NPHC) Ligands, 2025, Angewandte Chemie International Edition

Frequent coauthors who have collaborated extensively with Ann B. Hill include:

  • Michael W. Munks
  • Katherine H. Rott
  • Savannah M. Smart
  • Pavlo A. Nesterenko
  • Venasha Williams

The scientist's works are often published in journals such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • ANZ Journal of Surgery
  • PLoS Pathogens
  • European Journal of Immunology
  • The Journal of Immunology

Best Publications

  • Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

    Hisashi Arase;Edward S. Mocarski;Ann E. Campbell;Ann B. Hill

  • Herpes simplex virus turns off the TAP to evade host immunity

    Ann Hill;Pieter Jugovic;lan York;Gustav Russ

  • T cells and viral persistence: lessons from diverse infections

    Paul Klenerman;Ann Hill

  • Memory Inflation During Chronic Viral Infection is Maintained by Continuous Production of Short-Lived Functional T Cells

    Christopher M. Snyder;Kathy S. Cho;Elizabeth L. Bonnett;Serani van Dommelen

  • Viral interference with antigen presentation.

    Jonathan W. Yewdell;Ann B. Hill

  • Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin

    Bin Gao;Raju Adhikari;Raju Adhikari;Mark Howarth;Mark Howarth;Kimitoshi Nakamura

  • Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

    R Tomazin;A B Hill;P Jugovic;I York

  • Four Distinct Patterns of Memory CD8 T Cell Responses to Chronic Murine Cytomegalovirus Infection

    Michael W. Munks;Kathy S. Cho;Amelia K. Pinto;Sophie Sierro

  • A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface

    Maurits F. Kleijnen;Johannes B. Huppa;Pero Lucin;Siddhartha Mukherjee

  • Genome-Wide Analysis Reveals a Highly Diverse CD8 T Cell Response to Murine Cytomegalovirus

    Michael W. Munks;Marielle C. Gold;Allison L. Zajac;Carmen M. Doom

  • CMV and Immunosenescence: from basics to clinics

    Rafael Solana;Raquel Tarazona;Allison E Aiello;Arne N Akbar

  • HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2.

    Ann B. Hill;Barbara C. Barnett;Andrew J. McMichael;Duncan J. McGeoch

  • The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues

    Begoña Galocha;Ann Hill;Barbara C. Barnett;Aidan Dolan

  • Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response

    Agnieszka Kielczewska;Michal Pyzik;Tianhe Sun;Astrid Krmpotic

  • Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.

    Christopher M. Snyder;Kathy S. Cho;Elizabeth L. Bonnett;Jane E. Allan

  • The Murine Cytomegalovirus Immunomodulatory Gene m152 Prevents Recognition of Infected Cells by M45-Specific CTL But Does Not Alter the Immunodominance of the M45-Specific CD8 T Cell Response In Vivo

    Marielle C. Gold;Michael W. Munks;Markus Wagner;Ulrich H. Koszinowski

  • The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.

    Daniel G. Kavanagh;Marielle C. Gold;Markus Wagner;Ulrich H. Koszinowski

  • Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.

    Ann B. Hill;Steven P. Lee;John S. Haurum;Nick Murray

  • Cytomegaloviruses use multiple mechanisms to elude the host immune response.

    Emmanuel Wiertz;Ann Hill;Dominic Tortorella;Hidde Ploegh

  • Subdominant CD8 T-Cell Epitopes Account for Protection against Cytomegalovirus Independent of Immunodomination

    Rafaela Holtappels;Christian O. Simon;Michael W. Munks;Doris Thomas

Frequent Co-Authors

Ulrich H. Koszinowski
Ulrich H. Koszinowski Ludwig-Maximilians-Universität München
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Hidde L. Ploegh
Hidde L. Ploegh Boston Children's Hospital
Robert V. Blanden
Robert V. Blanden Australian National University
Arno Müllbacher
Arno Müllbacher Australian National University
Jos A. Bosch
Jos A. Bosch University of Amsterdam
Paul Klenerman
Paul Klenerman University of Oxford
Mark R. Wills
Mark R. Wills University of Cambridge
Sarah Rowland-Jones
Sarah Rowland-Jones University of Sheffield

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing healthcare-related degrees can provide valuable pathways into the field. Many students start with nursing programs that offer strong foundational knowledge applicable to immunology research and clinical practice. Notably, accelerated fnp programs allow registered nurses to quickly advance their careers while deepening their clinical expertise, which is beneficial when specializing in immunological conditions.

Non-nurses contemplating a career shift may explore online rn programs for non nurses in florida. These programs provide fast-track options to enter nursing, creating more opportunities to work within immunology-focused departments or research centers.

Applicants seeking easier entry into the nursing profession might consider absn programs with high acceptance rates. These programs prioritize accessibility without compromising essential clinical training, a crucial step for those eager to bridge into immunology roles.

Another accessible pathway includes easy admission lpn programs, which offer a gateway into licensed practical nursing. This provides practical patient care experience, laying groundwork for advanced studies or careers in immunological healthcare environments.

Best Scientists Citing Ann B. Hill

Trending Scientists

Recently Published Articles